Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AXSOME-THERAPEUTICS-INC-24949017/news/Axsome-Therapeutics-Inc-Announces-AXS-12-Achieves-Primary-Endpoint-in-the-SYMPHony-Phase-3-Trial-i-46293908/?utm_source=whatsapp&utm_medium=social&utm_campaign=share